Eli Lilly's stock tumbled 8% on Tuesday after it forecast fourth-quarter sales of weight-loss drug Zepbound below Wall Street ...

The Centers for Medicare and Medicaid Services (CMS) identified 15 drugs it has selected for price negotiations with drug ...

The findings, based on an analysis of records from 2.5 million VA patients, support much of what scientists already suspected ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...

A new study highlighted Monday the potential benefits of popular diabetes drugs on a wide range of health issues including dementia and cardiovascular diseases, although experts warned against seeing ...

Diabetes and weight loss drugs Ozempic and Wegovy have been added to the list of medications selected for Medicare price ...

The Biden administration moved Friday to negotiate the prices Medicare pays for the blockbuster weight-loss drugs ... of a new Medicare initiative aimed at lowering prescription drug prices ...

Since Wegovy’s FDA approval in 2021, Ozempic has often been prescribed ... Why Ozempic and New Weight-Loss Drugs Are Different The emergence of semaglutide has ushered in a new era of obesity ...

Semaglutide 7.2 mg significantly outperformed semaglutide 2.4 mg and placebo with a 20.7% average reduction in weight and a ...

They’re both once-a-week injectable drugs designed to help patients with type 2 diabetes manage blood sugar. And they’re both prescribed off-label for weight loss. But this still leaves many ...

Insanely beautiful and glossy people are telling me why I should or shouldn't take weight loss ... New York. After seeing celebrities using Ozempic, she went to her doctor and asked for the drug.